SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-4/A - Registration of securities, business combinations: [Amend]
SEC Accession No. 0001193125-20-091055
Filing Date
2020-03-30
Accepted
2020-03-30 17:02:25
Documents
14

Document Format Files

Seq Description Document Type Size
1 S-4/A d875861ds4a.htm S-4/A 4541079
2 EX-5.1 d875861dex51.htm EX-5.1 13030
3 EX-8.1 d875861dex81.htm EX-8.1 19487
4 EX-8.2 d875861dex82.htm EX-8.2 14864
5 EX-23.1 d875861dex231.htm EX-23.1 1355
6 EX-23.2 d875861dex232.htm EX-23.2 1721
7 EX-99.1 d875861dex991.htm EX-99.1 6484
8 GRAPHIC g875861g00r86.jpg GRAPHIC 68916
9 GRAPHIC g875861g30h41.jpg GRAPHIC 34754
10 GRAPHIC g875861g57g90.jpg GRAPHIC 156798
11 GRAPHIC g875861g67n67.jpg GRAPHIC 137500
12 GRAPHIC g875861g83r77.jpg GRAPHIC 6022
13 GRAPHIC g875861g86v26.jpg GRAPHIC 5631
14 GRAPHIC g875861img005.jpg GRAPHIC 9086
  Complete submission text file 0001193125-20-091055.txt   5149842
Mailing Address 16745 WEST BERNARDO DRIVE SUITE 250 San Diego CA 92127
Business Address 16745 WEST BERNARDO DRIVE SUITE 250 San Diego CA 92127 (858) 376-2600
Conatus Pharmaceuticals Inc. (Filer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-4/A | Act: 33 | File No.: 333-236332 | Film No.: 20758014
SIC: 2834 Pharmaceutical Preparations